Cargando…

Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay

OBJECTIVES: To assess whether a commercially available CE-IVD, ELISA-based surrogate neutralisation assay (cPass, Genscript) provides a genuine measure of SARS-CoV-2 neutralisation by human sera, and further to establish whether measuring responses against the RBD of S was a diagnostically useful pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murray, Matthew J., McIntosh, Megan, Atkinson, Claire, Mahungu, Tabitha, Wright, Edward, Chatterton, Wendy, Gandy, Michael, Reeves, Matthew B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	W.B. Saunders 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7979278/ https://www.ncbi.nlm.nih.gov/pubmed/33753152 http://dx.doi.org/10.1016/j.jinf.2021.03.010

Ejemplares similares

Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays
por: Hyseni, Inesa, et al.
Publicado: (2020)

A robust lentiviral pseudotype neutralisation assay for in-field serosurveillance of rabies and lyssaviruses in Africa
por: Wright, Edward, et al.
Publicado: (2009)

Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay
por: Bentley, Emma M., et al.
Publicado: (2021)

Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature
por: Cantoni, Diego, et al.
Publicado: (2023)

Studying longitudinal neutralising antibody levels against Equid herpesvirus 1 in experimentally infected horses using a novel pseudotype based assay
por: Genova, Cecilia Di, et al.
Publicado: (2023)

Pseudotyping of VSV with Ebola virus glycoprotein is superior to HIV-1 for the assessment of neutralising antibodies
por: Steeds, Kimberley, et al.
Publicado: (2020)

Challenges on the development of a pseudotyping assay for Zika glycoproteins
por: Ruiz-Jiménez, Fernando, et al.
Publicado: (2021)

Evaluation of a Pseudotyped Virus Neutralisation Test for the Measurement of Equine Influenza Virus-Neutralising Antibody Responses Induced by Vaccination and Infection
por: Kinsley, Rebecca, et al.
Publicado: (2020)

Pseudotype-Based Neutralization Assays for Influenza: A Systematic Analysis
por: Carnell, George William, et al.
Publicado: (2015)

Chimeric influenza haemagglutinins: Generation and use in pseudotype neutralization assays
por: Ferrara, Francesca, et al.
Publicado: (2016)

Pseudotype Neutralization Assays: From Laboratory Bench to Data Analysis
por: Ferrara, Francesca, et al.
Publicado: (2018)

A review of commercially available thrombin generation assays
por: Kintigh, Jeremy, et al.
Publicado: (2017)

Spectrophotometric-Based Assay to Quantify Relative Enzyme-Mediated Degradation of Commercially Available Bioplastics
por: Hoekstra, Matthew, et al.
Publicado: (2023)

A Functional Henipavirus Envelope Glycoprotein Pseudotyped Lentivirus Assay System
por: Khetawat, Dimple, et al.
Publicado: (2010)

The role of pseudotype neutralization assays in understanding SARS CoV-2
por: Cantoni, Diego, et al.
Publicado: (2021)

Validation of an Indirect Immunofluorescence Assay and Commercial Q Fever Enzyme-Linked Immunosorbent Assay for Use in Macropods
por: Tolpinrud, Anita, et al.
Publicado: (2022)

Induction of Broadly Neutralising HCV Antibodies in Mice by Integration-Deficient Lentiviral Vector-Based Pseudotyped Particles
por: Deng, Yao, et al.
Publicado: (2013)

Evaluation of Commercially Available Chikungunya Virus Immunoglobulin M Detection Assays
por: Johnson, Barbara W., et al.
Publicado: (2016)

Clinical validation of an open-access SARS-COV-2 antigen detection lateral flow assay, compared to commercially available assays
por: Bachman, Christine M., et al.
Publicado: (2021)

Standardised neutralising antibody assays are needed for evaluating COVID-19 vaccines
por: Wang, Youchun
Publicado: (2021)

The Use of Hyperimmune Chicken Reference Sera Is Not Appropriate for the Validation of Influenza Pseudotype Neutralization Assays
por: Ferrara, Francesca, et al.
Publicado: (2017)

Development of a neutralization assay based on the pseudotyped chikungunya virus of a Korean isolate
por: Chung, Woo-Chang, et al.
Publicado: (2019)

Production of Human papillomavirus pseudovirions in plants and their use in pseudovirion-based neutralisation assays in mammalian cells
por: Lamprecht, Renate L, et al.
Publicado: (2016)

Determining Vitamin D Status: A Comparison between Commercially Available Assays
por: Snellman, Greta, et al.
Publicado: (2010)

Performance of commercially available anti-HDV enzyme-linked immunosorbent assays in Taiwan
por: Lin, Guan-Yu, et al.
Publicado: (2020)

In Vitro Assay of Translation Inhibition by Trichothecenes Using a Commercially Available System
por: Toyotome, Takahito, et al.
Publicado: (2021)

Comparison of six commercially available SARS-CoV-2 antibody assays—Choice of assay depends on intended use
por: Nilsson, Anna Christine, et al.
Publicado: (2021)

Efficient generation of vesicular stomatitis virus (VSV)-pseudotypes bearing morbilliviral glycoproteins and their use in quantifying virus neutralising antibodies
por: Logan, Nicola, et al.
Publicado: (2016)

Package of NDV-Pseudotyped HIV-Luc Virus and Its Application in the Neutralization Assay for NDV Infection
por: Wang, Bin, et al.
Publicado: (2014)

An Innovative Pseudotypes-Based Enzyme-Linked Lectin Assay for the Measurement of Functional Anti-Neuraminidase Antibodies
por: Prevato, Marua, et al.
Publicado: (2015)

Development of in vitro and in vivo neutralization assays based on the pseudotyped H7N9 virus
por: Tian, Yabin, et al.
Publicado: (2018)

A sensitive retroviral pseudotype assay for influenza H5N1‐neutralizing antibodies
por: Temperton, Nigel J., et al.
Publicado: (2007)

Comparison of JEV neutralization assay using pseudotyped JEV with the conventional plaque-reduction neutralization test
por: Lee, Hee-Jung, et al.
Publicado: (2014)

A temperature-dependent virus-binding assay reveals the presence of neutralizing antibodies in human cytomegalovirus gB vaccine recipients’ sera
por: Gomes, Ariane C., et al.
Publicado: (2023)

Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions
por: Zheng, Yue, et al.
Publicado: (2021)

Neutralization Assay with SARS-CoV-1 and SARS-CoV-2 Spike Pseudotyped Murine Leukemia Virions
por: Zheng, Yue, et al.
Publicado: (2020)

Correction: Determining Vitamin D Status: A Comparison between Commercially Available Assays
por: Snellman, Greta, et al.
Publicado: (2010)

Overview of Commercially Available PCR Assays for the Detection of Aspergillus spp. DNA in Patient Samples
por: Rath, Peter-Michael, et al.
Publicado: (2018)

Optimisation of a micro-neutralisation assay and its application in antigenic characterisation of influenza viruses
por: Lin, Yipu, et al.
Publicado: (2015)

Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
por: Crawford, Katharine H. D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9o0ur7mhi2l02f8pnrppg19na3